These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4890820)

  • 1. Further studies on artificial antigens and immunity to mouse typhoid. II. The ability of galactans containing various acyl groups to immunise mice against mouse typhoid.
    Jackson GD; Jenkin CR
    Aust J Exp Biol Med Sci; 1969 Feb; 47(1):91-6. PubMed ID: 4890820
    [No Abstract]   [Full Text] [Related]  

  • 2. Preparation of an artificial antigen and immunity to mouse typhoid.
    Jenkin CR; Karnovsky ML; Rowley D
    Immunology; 1967 Oct; 13(4):361-72. PubMed ID: 4861746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further studies with artificial antigens and immunity to mouse typhoid. I. Use of O acetylated galactans in the purification of specific antibody against antigen 5.
    Jackson GD; Rowley D; Jenkin CR
    Immunology; 1968 Dec; 15(6):789-98. PubMed ID: 4884961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of enteral immunization against typhoid fever with chemical Vi and O antigens.
    Pershin BB
    Fed Proc Transl Suppl; 1965; 24(6):1079-80. PubMed ID: 5321225
    [No Abstract]   [Full Text] [Related]  

  • 5. Protective capacity of L-form Salmonella typhimurium against murine typhoid in C3H/HeJ mice.
    Nishikawa F; Kita E; Yamada H; Nakano A; Kashiba S
    Microbiol Immunol; 1994; 38(2):129-37. PubMed ID: 8041300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically modified Bifidobacterium displaying Salmonella-antigen protects mice from lethal challenge of Salmonella Typhimurium in a murine typhoid fever model.
    Yamamoto S; Wada J; Katayama T; Jikimoto T; Nakamura M; Kinoshita S; Lee KM; Kawabata M; Shirakawa T
    Vaccine; 2010 Sep; 28(41):6684-91. PubMed ID: 20709009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Problems of anti-typhoid immunity and protective vaccination against typhoid.
    Karolcek J
    Lek Pr; 1969; 7(1):3-153. PubMed ID: 4917329
    [No Abstract]   [Full Text] [Related]  

  • 8. Artificial antigens and immunity to infectious disease.
    Jenkin CR; Jackson GD
    Prog Immunobiol Stand; 1970; 4():493-504. PubMed ID: 5482193
    [No Abstract]   [Full Text] [Related]  

  • 9. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further studies regarding the question of cellular immunity in mouse typhoid.
    Rowley D; Auzins I; Jenkin CR
    Aust J Exp Biol Med Sci; 1968 Aug; 46(4):447-63. PubMed ID: 4879050
    [No Abstract]   [Full Text] [Related]  

  • 11. Salmonella enterica serovar Typhimurium strain lacking pmrG-HM-D provides excellent protection against salmonellosis in murine typhoid model.
    Negi VD; Singhamahapatra S; Chakravortty D
    Vaccine; 2007 Jul; 25(29):5315-23. PubMed ID: 17574312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium.
    Colwell DE; Michalek SM; Briles DE; Jirillo E; McGhee JR
    J Immunol; 1984 Aug; 133(2):950-7. PubMed ID: 6203984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
    Pakkanen SH; Kantele JM; Herzog C; Kantele A
    Vaccine; 2014 Jan; 32(5):544-51. PubMed ID: 24342246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of the protective immunity against murine typhoid: persistence of Salmonella L forms in the liver after immunization with live-cell vaccines.
    Kita E; Nishikawa F; Kamikaidou N; Oku D; Yasui K; Kashiba S
    FEMS Microbiol Immunol; 1992 Oct; 5(4):191-9. PubMed ID: 1419117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contribution of agglutination reactions to the diagnosis of typhoid fever].
    Bancalari A; Banfi A
    Rev Chil Pediatr; 1979; 50(2):27-30. PubMed ID: 395578
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunization against typhoid: a short review.
    Bhatia RS; Sibia SS
    J Assoc Physicians India; 1994 May; 42(5):424. PubMed ID: 7829448
    [No Abstract]   [Full Text] [Related]  

  • 17. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
    Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assay of typhoid vaccines in mice.
    Sterne M; Trim G
    J Med Microbiol; 1974 May; 7(2):197-203. PubMed ID: 4600291
    [No Abstract]   [Full Text] [Related]  

  • 19. Conversion of Salmonella typhimurium to L-forms contributes to the maintenance of acquired immunity against murine typhoid.
    Kita E; Emoto M; Nishikawa F; Yoshikai Y; Kashiba S
    Immunology; 1995 Oct; 86(2):206-11. PubMed ID: 7490119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunity in typhoid fever. II. Antigens and immune response in systemic salmonellosis].
    Milhomem AM; Suassuna I
    Mem Inst Oswaldo Cruz; 1982; 77(4):453-83. PubMed ID: 6764521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.